First step toward CRISPR cure of Lou Gehrig’s disease
12/20/17 — Berkeley scientists led by Davis Shaffer, professor of chemical and biomolecular engineering and bioengineering, have for the first time used CRISPR-Cas9 gene editing to disable a defective gene that causes amyotrophic lateral sclerosis in mice, extending their lifespan by 25 percent.